TRT Clinics: AI Market Discovery Index
Tracking how AI platforms recommend trt clinics. This public AI Market Discovery Index is updated monthly since July 2026.

On this page
- 01Benchmark Summary
- 02Current Benchmark at a Glance
- 03Research Scope and Qualification
- 04Current Brand Standings
- 05How to Read the Standings
- 06Recommendation Coverage Movement
- 07Largest Decline: Henry Meds
- 08Largest Decline: Low T Center
- 09Category Leader: Defy Medical
- 10Recommendation Placement Snapshot
- 11Buyer-Intent Distribution
- 12Historical Measurement Record
Benchmark Summary
Defy Medical led valid recommendation coverage in August 2026 at 47.4%, tied with Hone Health at 47.4%. The two brands ended the month in a statistical tie at the top of the benchmark.
The largest coverage increase in August 2026 was Marek Health, which rose to 21.5% from 20.6% in July 2026. The largest coverage declines were Henry Meds, down to 13.9% from 23.9% in July 2026, and Low T Center, down to 2.4% from 7.7% in July 2026. Both declines went beyond normal month-to-month variation. Maximus held steady at 28.2% in August 2026, down from 28.7% in July 2026.
The benchmark began with 800 prompt-surface observations in each month and produced 209 qualified observations in August 2026 after qualification.
AI recommendation trend
valid recommendation coverage, Jul 2026 to Aug 2026
- Defy Medical-1.4%Jul 202648.8%Aug 202647.4%
- Hone Health-5.7%Jul 202653.1%Aug 202647.4%
- Maximus-0.5%Jul 202628.7%Aug 202628.2%
- Marek Health+0.9%Jul 202620.6%Aug 202621.5%
- Henry Meds-10.0% · beyond normal variationJul 202623.9%Aug 202613.9%
- Fountain TRT-2.4%Jul 202611.0%Aug 20268.6%
- Low T Center-5.3% · beyond normal variationJul 20267.7%Aug 20262.4%
- Renew Vitality+0.5%Jul 20261.9%Aug 20262.4%
- Craft Conciergeno changeJul 20261.0%Aug 20261.0%
- BioTEno changeJul 20260.0%Aug 20260.0%
Current Benchmark at a Glance
Measure | Jul 2026 | Aug 2026 | Movement |
|---|---|---|---|
Qualified benchmark observations | 209 | 209 | No change |
Tracked brands | 10 | 10 | No change |
Qualified surface breadth | 6 | 6 | No change |
Recommendation-shaped answer share | 39.7% | 49.8% | Up 10.1 points |
Valid recommendation shortlist share | 64.6% | 63.6% | Down 1.0 points |
Leader by valid recommendation coverage | Hone Health | Defy Medical | Changed |
Qualified surface breadth counts the six canonical AI surface families with at least one qualified observation: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode. Breadth held at six surfaces in both months.
For the strategic interpretation of this benchmark, read CiteWorks Studio's analysis of How AI Search Is Recommending TRT Clinics
Research Scope and Qualification
The public benchmark is narrower than the raw collection universe by design.
Research stage | Jul 2026 | Aug 2026 | What it represents |
|---|---|---|---|
Source prompt-surface observations | 800 | 800 | Total prompts run across AI/search surfaces |
Unique questions | 461 | 532 | Distinct questions after deduplication |
Brand / competitor mentions | 800 | 799 | Prompts mentioning at least one tracked brand |
Relevant observations | 419 | 405 | On-topic responses retained for analysis |
Irrelevant observations | 381 | 394 | Off-topic responses excluded |
Qualified benchmark observations | 209 | 209 | Public denominator after reservation |
Brand-level percentages use the qualified observations as the public denominator, not the raw collection. AI Market Discovery Methodology
Current Brand Standings
Brand | Presence rate | Valid recommendation coverage | Top-three rate | Rank-one rate | Net sentiment |
|---|---|---|---|---|---|
Defy Medical | 55.5% | 47.4% | 26.8% | 4.8% | 0.9 |
Hone Health | 70.3% | 47.4% | 33.0% | 12.9% | 0.8 |
Maximus | 34.9% | 28.2% | 17.2% | 9.1% | 0.9 |
Marek Health | 24.9% | 21.5% | 12.0% | 1.0% | 0.9 |
Henry Meds | 22.0% | 13.9% | 6.2% | 0.5% | 0.7 |
Fountain TRT | 10.5% | 8.6% | 1.4% | 0.0% | 0.8 |
Low T Center | 10.5% | 2.4% | 0.5% | 0.0% | 0.3 |
Renew Vitality | 6.2% | 2.4% | 0.0% | 0.0% | 0.5 |
Craft Concierge | 1.0% | 1.0% | 0.0% | 0.0% | 1.0 |
BioTE | 1.9% | 0.0% | 0.0% | 0.0% | 0.0 |
How to Read the Standings
Want the full Authority Index
The paid deep-dive adds competitor threat profiles, the gap matrix, citation failure map, platform-by-platform recovery roadmap, and client-specific economic modeling.
Presence rate is the share of qualified observations in which a brand appears at all. Valid recommendation coverage is the share of qualified observations in which a brand receives a clear, actionable recommendation. Top-three rate measures how often a brand appears among the first three recommendations. Rank-one rate measures how often a brand is the first recommendation. Net sentiment runs from -1 to +1 and reflects the tone of brand mentions.
For formulas and denominator rules, see AI Market Discovery Metric Definitions.
Recommendation Coverage Movement
Brand | Jul 2026 | Aug 2026 | Movement since baseline |
|---|---|---|---|
BioTE | 0.0% | 0.0% | No change |
Craft Concierge | 1.0% | 1.0% | No change |
Defy Medical | 48.8% | 47.4% | Down 1.4 points |
Fountain TRT | 11.0% | 8.6% | Down 2.4 points |
Henry Meds | 23.9% | 13.9% | Down 10.0 points |
Hone Health | 53.1% | 47.4% | Down 5.7 points |
Low T Center | 7.7% | 2.4% | Down 5.3 points |
Marek Health | 20.6% | 21.5% | Up 0.9 points |
Maximus | 28.7% | 28.2% | Down 0.5 points |
Renew Vitality | 1.9% | 2.4% | Up 0.5 points |
Largest Decline: Henry Meds
Henry Meds valid recommendation coverage fell to 13.9% in August 2026 from 23.9% in July 2026, a drop of 10.0 points that went beyond normal month-to-month variation. The brand was recommended to valid recommendation counts of 29 in August 2026, down from 50 in July 2026. Presence rate also eased to 22.0% in August 2026 from 26.8% in July 2026.
Largest Decline: Low T Center
Low T Center valid recommendation coverage fell to 2.4% in August 2026 from 7.7% in July 2026, a drop of 5.3 points that went beyond normal month-to-month variation. The brand held valid recommendation counts of 5 in August 2026, down from 16 in July 2026. Rank-one rate fell to 0.0% in August 2026 from 3.4% in July 2026.
Category Leader: Defy Medical
Defy Medical and Hone Health closed August 2026 with identical valid recommendation coverage at 47.4%. Defy Medical moved down from 48.8% in July 2026; Hone Health moved down from 53.1% in July 2026. Hone Health held a rank-one rate more than twice as high as Defy Medical's in August 2026 (12.9% versus 4.8%), despite Defy Medical's lower presence rate at 55.5% versus Hone Health's 70.3%.
Want the full Authority Index
The paid deep-dive adds competitor threat profiles, the gap matrix, citation failure map, platform-by-platform recovery roadmap, and client-specific economic modeling.
Recommendation Placement Snapshot
Coverage alone does not show how prominently a brand is recommended. Among the leaders in August 2026, placement varied meaningfully.
Brand | Aug 2026 top-three rate | Aug 2026 rank-one rate | Jul 2026 top-three rate | Jul 2026 rank-one rate |
|---|---|---|---|---|
Defy Medical | 26.8% | 4.8% | 23.9% | 4.3% |
Hone Health | 33.0% | 12.9% | 36.4% | 10.1% |
Maximus | 17.2% | 9.1% | 14.3% | 7.7% |
Close coverage can hide different first-position rates. Hone Health matched Defy Medical on coverage in August 2026 but held a rank-one rate more than twice as high.
Buyer-Intent Distribution
All qualified observations in both months fell into the Brand Recommendation class.
Buyer-intent class | Jul 2026 | Aug 2026 |
|---|---|---|
Brand Recommendation | 209 | 209 |
Pricing & Value | 0 | 0 |
Multi-Brand Comparison | 0 | 0 |
Total qualified observations | 209 | 209 |
The current public series measures Brand Recommendation discovery only and does not yet contain qualified observations in the Pricing & Value or Multi-Brand Comparison classes.
Historical Measurement Record
This is an evergreen benchmark URL. New measurements are added to the same report.
Measurement | Qualified observations | Coverage leader | Leader coverage | Largest coverage movement |
|---|---|---|---|---|
Jul 2026 | 209 | Hone Health | 53.1% | Hone Health covering over half of observations |
Aug 2026 | 209 | Defy Medical | 47.4% | Henry Meds down 10.0 points |
Evidence and Source Layer
The benchmark is built from prompt-level observations that retain the query, AI/search surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources. Source presence is evidence about the information environment. It is not automatically proof that the source caused the recommendation.
Scope Boundaries
This public benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, social mention volume, or private or sponsored channels. A metric movement alone does not establish causality.
About This Benchmark
The LLM Authority Index AI Market Discovery Index tracks how often brands appear and are recommended across six canonical AI and search surface families, providing an industry-level view of AI-driven discovery.
- AI Market Discovery Methodology
- AI Market Discovery Metric Definitions
- AI Market Discovery Research Standards
- Modeled AI Authority Value
Get a Company-Level Authority Index
The public industry benchmark shows category-level standings. A company-level Authority Index can go deeper.
Want the full Authority Index
The paid deep-dive adds competitor threat profiles, the gap matrix, citation failure map, platform-by-platform recovery roadmap, and client-specific economic modeling.
Keep reading
Related posts
Industry Reports
IVF Clinics: AI Market Discovery Index
Read this blog on LLM Authority Index.
ReadIndustry Reports
Fertility Clinics: AI Market Discovery Index
Read this blog on LLM Authority Index.
ReadIndustry Reports
Revenue Cycle Management: AI Market Discovery Index
Read this blog on LLM Authority Index.
Read